Hypertension
Hypertension
Search
The Research Process
The Research Process
NASH
NASH
75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria
Veterinarians go above and (far) beyond.
Veterinarians go above and (far) beyond.
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
We are there for our patients – even in crisis regions.
We are there for our patients – even in crisis regions.
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Science & Innovation
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Fact & Figures Boehringer Ingelheim RCV
Facts and figures speak a clear language. Only economic success enables us to implement our corporate vision.
Biotherapeutics Discovery
Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
Veterinarians: caught between excellence and exhaustion
Many children dream of becoming a veterinarian. What happens when that dream comes true?
All hands-on deck to fight the ‘zombie’ rabies virus
We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships.
Our FOCUS
Our FOCUS
About Our Innovation Prize
Celebrating Our Innovation Prize Winners
Digital innovation: „We change the way labs work“
QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
Uniting to stop rabies: a global and local endeavor
By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease
How Boehringer Ingelheim is Supporting Grass Roots Innovation
Our Grass Roots activities support life-science innovators with mentoring and networking opportunities
Pride Month: Colleagues from the LGBTQIA+ community and allies share their views on our culture of respect
In June, as the world celebrates Pride Month, we asked three of our colleagues to share their thoughts on the significance of respect at our company.
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
“My ultimate goal is to cure cancer”
“My ultimate goal is to cure cancer”
Privacy Notice
Privacy Notice
Code of Conduct
Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
Schizophrenia in real life
Through these real-life stories, discover the eye-opening reality of life with schizophrenia.